Fas and WAF1 expression in esophageal squamous cell carcinomas

International Surgery

Volumn 91, Issue 6, 2006, Pages 320-325

  Vlachos, Konstantinos ^a,b,h   Siafakas, Nikolaos ^c   Karameris, Andreas ^d   Athanasas, George ^a   Theodoropoulos, George ^e   Parassi, Ekaterini ^f   Peros, George ^a   Papadopoulos, Jordan ^a   Hakim, Nadey ^g  

^a UNIVERSITY OF ATHENS   (Greece)

^b ST MARY S HOSPITAL   (United Kingdom)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

^d 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^e HIPPOKRATION HOSPITAL   (Greece)

^f IASO GENERAL HOSPITAL   (Greece)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

^h Medical Officer of the Hellenic Army   (United Kingdom)

Author keywords

Apoptosis; Esophagus; Immunohistochemistry; WAF1 and Fas

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FAS ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL;

ANTIGENS, CD95; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED;

EID: 33846342146     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Swisher SG, Hunt KK, Holmes EC, Zinner MJ, McFadden DW. Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg 1995;169:609-613
2. Munoz N and Castellsague X. Epidemiology of oesophageal cancer: Eur J Gastroenterol Hepatol 1994;6:649-655
3. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-1294
4. Shibakita M, Tachibana M, Dhar DK, Ohno S, Kubota H, Yoshimura H et al. Spontaneous apoptosis in advanced esophageal carcinoma: its relation to Fas expression. Clin Cancer Res 2000;6:4755-4759
5. Itoh N, Tsujimoto Y, Nagata S. Effect of Bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-627
6. Sadanaga N, Kuwano H, Watanabe M, Maekawa S, Mori M, Sugimachi K. Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration. Cancer 1994;74:586-591
7. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825
8. El Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-1175
9. Wang J, Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 1996;273: 359-363
10. waf1/cip1 cyclin dependent inhibitor gene: association with human esophageal cencer. Oncogene 2000;19:323-328
11. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancers and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996;69:2225-2235
12. Sarbia M, Bittinger F, Porschen R, Verret P, Dutkowski P, Willers R et al. Bcl-2 expression and prognosis in squamous-cell carcinoma of the esophagus. Int J Cancer 1996;69: 324-328
13. L. Int Surg (in press)
14. Gratas K, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H. Up-regulation of Fas (APO-1/CD95) ligand and down regulation of Fas expression in human esophageal cancer. Cancer Res 1998;58:2057-2062
15. WAF1/CIP1 in oesophageal squamous cell carcinomas. Virchows Arch 1997;430:389- 395
16. WAF1/Cip1 expression is associated with cell differentiation but not p53 mutations in squamous cell cercinomas of the larynx. J Pathol 1997;183:156-163
17. WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Clin Cancer Res 1999;5: 2445-2449